Emodin prevents intima thickness via Wnt4/Dvl-1/β-catenin signaling pathway mediated by miR-126 in balloon-injured carotid artery rats

Experimental and Molecular Medicine

Volumn 47, Issue 6, 2015, Pages

  Hua, Jun Yi ^a   He, Yu Zhou ^a   Xu, Yun ^a   Jiang, Xu Hong ^a   Ye, Wu ^a   Pan, Zhi Min ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DISHEVELLED PROTEIN; DVL1 PROTEIN, RAT; EMODIN; MICRORNA; MIRN126 MICRORNA, RAT; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WNT4 PROTEIN;

ANIMAL; CAROTID ARTERY; CAROTID ARTERY INJURIES; CELL PROLIFERATION; DRUG EFFECTS; INTIMA; MALE; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL PROLIFERATION; DISHEVELLED PROTEINS; EMODIN; MALE; MICRORNAS; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUNICA INTIMA; WNT4 PROTEIN;

EID: 85018194928     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2015.36     Document Type: Article

References (24)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT et al. A Polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221–231.
2. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R et al. Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 2008; 23: 75–82.
3. Patti G, Nusca A, Di Sciascio G. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Am J Cardiol 2008; 102: 1328–1334.
4. Mnjoyan ZH, Doan D, Brandon JL, Felix K, Sitter CL, Rege AA et al. The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia. Am J Physiol Heart Circ Physiol 2008; 294: H2276–H2284.
5. He L, Bi JJ, Guo Q, Yu Y, Ye XF. Effects of emodin extracted from Chinese herbs on proliferation of non-small cell lung cancer and underlying mechanisms. Asian Pac J Cancer Prev 2012; 13: 1505–1510.
6. Lin SZ, Wei WT, Chen H, Chen KJ, Tong HF, Wang ZH et al. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. PLoS One 2012; 7: e42146.
7. Manu KA, Shanmugam MK, Ong TH, Subramaniam A, Siveen KS, Perumal E et al. Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma. PLoS One 2013; 8: e57015.
8. Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L et al. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. Br J Pharmacol 2013; 170: 807–821.
9. Yin C, Xu C. Effect of aloe-emodin on proliferation of vascular smooth muscle cells after arterial injury. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998; 18: 420–422.
10. Wang X, Zou Y, Sun A, Xu D, Niu Y, Wang S et al. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53. J Cardiovasc Pharmacol 2007; 49: 253–260.
11. Heo SK, Yun HJ, Park WH, Park SD. Emodin inhibits TNF-alpha-induced human aortic smooth-muscle cell proliferation via caspase-and mitochondrial-dependent apoptosis. J Cell Biochem 2008; 105: 70–80.
12. Wang X, Adhikari N, Li Q, Hall JL. The LDL receptor related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004; 287: H2376–H2383.
13. Marchand A, Atassi F, Gaaya A, Leprince P, Le Feuvre C, Soubrier F et al. The Wnt/ beta-catenin pathway is activated during advanced arterial aging in humans. Aging Cell 2011; 10: 220–232.
14. Tsaousi A, Williams H, Lyon C, Taylor V, Swain A, Johnson J et al. Wnt4/b-catenin signalling induces VSMC proliferation and is associated with intimal thickening. Circ Res 2011; 108: 427–436.
15. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn M, Hall JL. A role for the b-catenin/ T-cell factor signaling cascade in vascular remodeling. Circ Res 2002; 90: 340–347.
16. Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC et al. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle proliferation. Circ Res 2003; 92: 1314–1321.
17. Slater SC, Koutsouki E, Jackson CL, Bush RC, Angelini GD, Newby AC et al. R-cadherin:β-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 2004; 24: 1204–1210.
18. Li PP, Wang X. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia. Chin Med J (Engl) 2013; 126: 4175–4182.
19. Caporali A, Emanueli C. MicroRNA regulation in angiogenesis. Vascul Pharmacol 2011; 55: 79–86.
20. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 2011; 106: 13–23.
21. Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU et al. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) 2010; 119: 335–343.
22. Mill C, George SJ. Wnt signaling in smooth muscle cells and its role in cardiovascular disorders. Cardiovasc Res 2012; 95: 233–240.
23. Osherov AB, Gotha L, Cheema AN, Qiang B, Strauss BH. Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy. Cardiovasc Res 2011; 91: 16–26.
24. Ye X, Hemida MG, Qiu Y, Hanson PJ, Zhang HM, Yang D. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/β-catenin signal pathways. Cell Mol Life Sci 2013; 70: 4631–4644.